Published in Cell Commun Adhes on July 25, 2003
ADAM-17: the enzyme that does it all. Crit Rev Biochem Mol Biol (2010) 1.62
Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. Carcinogenesis (2006) 0.93
Applications of snake venom components to modulate integrin activities in cell-matrix interactions. Int J Biochem Cell Biol (2013) 0.84
Selective amino acid restriction differentially affects the motility and directionality of DU145 and PC3 prostate cancer cells. J Cell Physiol (2008) 0.82
Antiproliferative effect of the jararhagin toxin on B16F10 murine melanoma. BMC Complement Altern Med (2014) 0.81
The unfolded protein response regulator GRP78/BiP as a novel target for increasing chemosensitivity in malignant gliomas. Cancer Res (2007) 2.82
Functional adult myocardium in the absence of Na+-Ca2+ exchange: cardiac-specific knockout of NCX1. Circ Res (2004) 2.82
Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. Blood (2009) 2.61
Dimethyl-celecoxib (DMC), a derivative of celecoxib that lacks cyclooxygenase-2-inhibitory function, potently mimics the anti-tumor effects of celecoxib on Burkitt's lymphoma in vitro and in vivo. Cancer Biol Ther (2005) 1.68
Differential effects of selective COX-2 inhibitors on cell cycle regulation and proliferation of glioblastoma cell lines. Cancer Biol Ther (2004) 1.65
Stress chaperone GRP78/BiP confers chemoresistance to tumor-associated endothelial cells. Mol Cancer Res (2008) 1.58
T2-TrpRS inhibits preretinal neovascularization and enhances physiological vascular regrowth in OIR as assessed by a new method of quantification. Invest Ophthalmol Vis Sci (2006) 1.53
Calcium-activated endoplasmic reticulum stress as a major component of tumor cell death induced by 2,5-dimethyl-celecoxib, a non-coxib analogue of celecoxib. Mol Cancer Ther (2007) 1.41
Primary intraosseous meningioma. Neurosurg Focus (2007) 1.39
HIV-1 protease inhibitors nelfinavir and atazanavir induce malignant glioma death by triggering endoplasmic reticulum stress. Cancer Res (2007) 1.30
Single-shot, multicycle suicide gene therapy by replication-competent retrovirus vectors achieves long-term survival benefit in experimental glioma. Mol Ther (2005) 1.25
Fasting enhances the response of glioma to chemo- and radiotherapy. PLoS One (2012) 1.18
Molecular genetics of meningiomas: a systematic review of the current literature and potential basis for future treatment paradigms. Neurosurg Focus (2011) 1.15
Aggravated endoplasmic reticulum stress as a basis for enhanced glioblastoma cell killing by bortezomib in combination with celecoxib or its non-coxib analogue, 2,5-dimethyl-celecoxib. Cancer Res (2008) 1.15
Celecoxib analogs that lack COX-2 inhibitory function: preclinical development of novel anticancer drugs. Expert Opin Investig Drugs (2008) 1.15
Highly efficient and tumor-restricted gene transfer to malignant gliomas by replication-competent retroviral vectors. Hum Gene Ther (2003) 1.12
Hypertrophy and heart failure in mice overexpressing the cardiac sodium-calcium exchanger. J Card Fail (2007) 1.11
Progenitor cells and retinal angiogenesis. Angiogenesis (2007) 1.10
Chapter 6. Ocular models of angiogenesis. Methods Enzymol (2008) 1.08
Inhibition of autophagy and induction of breast cancer cell death by mefloquine, an antimalarial agent. Cancer Lett (2012) 1.04
Downregulation of survivin expression and concomitant induction of apoptosis by celecoxib and its non-cyclooxygenase-2-inhibitory analog, dimethyl-celecoxib (DMC), in tumor cells in vitro and in vivo. Mol Cancer (2006) 1.03
Anti-angiogenesis and RGD-containing snake venom disintegrins. Curr Pharm Des (2007) 1.00
Use of replication-competent retroviral vectors in an immunocompetent intracranial glioma model. Neurosurg Focus (2006) 0.99
Characteristics of tumor-associated endothelial cells derived from glioblastoma multiforme. Neurosurg Focus (2006) 0.97
Interleukin-8 differentially regulates migration of tumor-associated and normal human brain endothelial cells. Cancer Res (2005) 0.97
Intravenous liposomal delivery of the snake venom disintegrin contortrostatin limits breast cancer progression. Mol Cancer Ther (2004) 0.95
Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non-COX-2 inhibitory analog of celecoxib. Blood (2005) 0.95
Development of a novel recombinant disintegrin, contortrostatin, as an effective anti-tumor and anti-angiogenic agent. Pathophysiol Haemost Thromb (2005) 0.92
Noscapine inhibits tumor growth in TMZ-resistant gliomas. Cancer Lett (2011) 0.91
Increased survivin expression confers chemoresistance to tumor-associated endothelial cells. Am J Pathol (2008) 0.91
Glioma-associated endothelial cells show evidence of replicative senescence. Exp Cell Res (2007) 0.91
DNA methylation in the malignant transformation of meningiomas. PLoS One (2013) 0.90
A-Mode ultrasound guidance for pedicle screw advancement in ovine vertebral bodies. Spine J (2010) 0.89
Glioma-associated endothelial cells are chemoresistant to temozolomide. J Neurooncol (2009) 0.89
Contortrostatin, a snake venom disintegrin with anti-angiogenic and anti-tumor activity. Pathophysiol Haemost Thromb (2005) 0.89
Functional and phenotypic differences between glioblastoma multiforme-derived and normal human brain endothelial cells. J Neurosurg (2005) 0.89
Chloroquine enhances temozolomide cytotoxicity in malignant gliomas by blocking autophagy. Neurosurg Focus (2014) 0.89
Perillyl alcohol for the treatment of temozolomide-resistant gliomas. Mol Cancer Ther (2012) 0.88
Preferential killing of triple-negative breast cancer cells in vitro and in vivo when pharmacological aggravators of endoplasmic reticulum stress are combined with autophagy inhibitors. Cancer Lett (2012) 0.87
Efficacy of celecoxib in the treatment of CNS lymphomas: an in vivo model. Neurosurg Focus (2006) 0.87
Nelfinavir potentiation of imatinib cytotoxicity in meningioma cells via survivin inhibition. Neurosurg Focus (2007) 0.86
Vicrostatin - an anti-invasive multi-integrin targeting chimeric disintegrin with tumor anti-angiogenic and pro-apoptotic activities. PLoS One (2010) 0.86
A novel method for administering intrathecal chemotherapy in patients with leptomeningeal metastases and shunted hydrocephalus: case report. Neurosurgery (2010) 0.85
Enhanced killing of chemo-resistant breast cancer cells via controlled aggravation of ER stress. Cancer Lett (2009) 0.85
Antiangiogenic activities of 2,5-dimethyl-celecoxib on the tumor vasculature. Mol Cancer Ther (2010) 0.84
An intensive, progressive exercise program reduces disability and improves functional performance in patients after single-level lumbar microdiskectomy. Phys Ther (2009) 0.82
Enhancement of glioblastoma cell killing by combination treatment with temozolomide and tamoxifen or hypericin. Neurosurg Focus (2006) 0.82
Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy. J Neurosurg (2005) 0.82
Preclinical development of novel anti-glioma drugs targeting the endoplasmic reticulum stress response. Curr Pharm Des (2011) 0.82
A phase 1/2 study of orally administered synthetic hypericin for treatment of recurrent malignant gliomas. Cancer (2011) 0.81
Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway. Cancer Lett (2002) 0.80
Genomic and transcriptome analysis revealing an oncogenic functional module in meningiomas. Neurosurg Focus (2013) 0.80
Anti-angiogenic activity of contortrostatin, a disintegrin from Agkistrodon contortrix contortrix snake venom. Angiogenesis (2003) 0.80
Development of immune memory to glial brain tumors after tumor regression induced by immunotherapeutic Toll-like receptor 7/8 activation. Oncoimmunology (2012) 0.80
Effective conversion of irinotecan to SN-38 after intratumoral drug delivery to an intracranial murine glioma model in vivo. Laboratory investigation. J Neurosurg (2010) 0.80
A systematic review of inhaled intranasal therapy for central nervous system neoplasms: an emerging therapeutic option. J Neurooncol (2014) 0.80
Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg Focus (2015) 0.79
Fibroblast growth factor-2-retargeted adenoviral vector for selective transduction of primary glioblastoma multiforme endothelial cells. Neurosurg Focus (2006) 0.79
Potent mimicry of fibronectin-induced intracellular signaling in glioma cells by the homodimeric snake venom disintegrin contortrostatin. Neurosurgery (2005) 0.79
Action of fenretinide (4-HPR) on ovarian cancer and endothelial cells. Anticancer Res (2005) 0.79
MicroRNA-18a improves human cerebral arteriovenous malformation endothelial cell function. Stroke (2013) 0.79
Structure of acostatin, a dimeric disintegrin from Southern copperhead (Agkistrodon contortrix contortrix), at 1.7 A resolution. Acta Crystallogr D Biol Crystallogr (2008) 0.79
Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat. Vaccine (2008) 0.78
Irinotecan: a potential new chemotherapeutic agent for atypical or malignant meningiomas. J Neurosurg (2007) 0.78
The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo. Prostate (2010) 0.78
The role of contortrostatin, a snake venom disintegrin, in the inhibition of tumor progression and prolongation of survival in a rodent glioma model. J Neurosurg (2005) 0.78
Multiple signaling pathways are involved in endothelin-1-induced brain endothelial cell migration. Am J Physiol Cell Physiol (2006) 0.77
Lumbar facet joint and intervertebral disc loading during simulated pelvic obliquity. Spine J (2013) 0.77
Repositioning of Verrucosidin, a purported inhibitor of chaperone protein GRP78, as an inhibitor of mitochondrial electron transport chain complex I. PLoS One (2013) 0.77
Pharmacogenomics of brain cancer and personalized medicine in malignant gliomas. Future Oncol (2008) 0.77
Purification, crystallization and preliminary X-ray analysis of the disintegrin contortrostatin from Agkistrodon contortrix contortrix snake venom. Acta Crystallogr D Biol Crystallogr (2002) 0.77
Contortrostatin, a homodimeric disintegrin isolated from snake venom inhibits herpes simplex virus entry and cell fusion. Antivir Ther (2012) 0.77
Multimeric disintegrin protein polymer fusions that target tumor vasculature. Biomacromolecules (2014) 0.77
Surgical interventions for primary central nervous system lymphoma. Neurosurg Focus (2006) 0.76
Reversal of thienopyridine-induced platelet dysfunction following desmopressin administration. J Med Toxicol (2013) 0.75
Hirudin and s18886 maintain luminal patency after thrombolysis with alfimeprase. J Cardiovasc Pharmacol (2013) 0.75
Transpedicular Corpectomy and Cage Placement in the Treatment of Traumatic Lumbar Burst Fractures. Clin Spine Surg (2017) 0.75
Effects of convection-enhanced delivery of bevacizumab on survival of glioma-bearing animals. Neurosurg Focus (2015) 0.75
Recent progress in our understanding of the pathogenesis of infantile hemangiomas. Lymphat Res Biol (2005) 0.75
The use of pepsin in receptor internalization assays. Biochem Biophys Res Commun (2009) 0.75
DuraSeal Spinal Sealant as an Adjunct to Sutured Dural Repair in the Spine: Results of a Prospective, Multicenter, Randomized, Controlled Study: 928. Neurosurgery (2009) 0.75
Introduction: Glioblastoma: an update on pathophysiology and management strategies. Neurosurg Focus (2014) 0.75